Satellite Sessions

October 19 | 12:45-13:45

Abbot Laboratories | October 19 | 12:45-13:45

Structural Heart – Tailored Therapy for Every Patient

 

 

To view full program click here

Novartis Israel | October 19 | 12:45-13:45

Dilemmas in CV Risk Management

 

To view full program click here

Novo Nordisk | October 19 | 12:45-13:45

ASCVD & T2D: Bridging the Evidence into Clinical Practice

 

To view full program click here

Bayer Israel | October 19 | 12:45-13:45

Diabetes Mellitus – Implications for Patients with Cardiovascular Disease

 

To view full program click here

October 19 | 16:15-17:15

Boehringer Ingelheim Israel LTD | October 19 | 16:15-17:15

The Future Trajectory for your HF Patient

 

To view full program click here

October 20 | 12:45-13:45

AstraZeneca (Israel) | October 20 | 12:45-13:45

A New Era in HF and Renal Disease Modification with sglt2i's

 

To view full program click here

Sanofi | October 20 | 12:45-13:45

Is there more to hyper-cholesterolemia management than LDL reduction?

Sub analyses of high risk groups from the Odyssey Outcome trial

 

To view full program click here

Pfizer Pharmaceuticals Israel | October 20 | 12:45-13:45

Where are the ATTR-CM patients? How to recognize and diagnose them

 

To view full program click here

October 20 | 16:15-17:15

Pfizer Pharmaceuticals Israel | October 20 | 16:15-17:15

How AI meets AF – Innovative Technologies for AF Detection

 

To view full program click here

Novo Nordisk | October 20 | 16:15-17:15

Time to Focus on Obesity Care